Immunogenicity and safety of SARS-COV-2 recombinant protein subunit vaccine (INDOVAC) in west Sumatera Province adolescents: A phase 3, observer blind, randomized, active-controlled

Vaccine: X · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles